# Ferroptosis in Patients With COPD COPD With/Without Risk of Cardiovascular Events. Pathophysiological Implications, Diagnostics and Prognoses. FerrEPOC Study.

> **NCT06102993** · — · UNKNOWN · sponsor: **Hospital Universitario Marqués de Valdecilla** · enrollment: 180 (estimated)

## Conditions studied

- COPD Exacerbation

## Interventions

- **OTHER:** Non-interventional study

## Key facts

- **NCT ID:** NCT06102993
- **Lead sponsor:** Hospital Universitario Marqués de Valdecilla
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-01
- **Primary completion:** 2024-10-01
- **Final completion:** 2025-10-01
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2023-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06102993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06102993, "Ferroptosis in Patients With COPD COPD With/Without Risk of Cardiovascular Events. Pathophysiological Implications, Diagnostics and Prognoses. FerrEPOC Study.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06102993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*